$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
研究证明舒尼替尼用于中国晚期RCC治疗安全有效
2025-10-19 11:44:20
Check Details
肾癌晚期肺转移的症状
2025-10-19 11:44:20
Check Details
舒尼替尼一线治疗亚裔肾癌患者疗效优异
2025-10-19 11:44:20
Check Details
依维莫司与乐伐替尼联用治疗肾癌
2025-10-19 11:44:20
Check Details
索拉非尼治疗肾癌,延长患者生存期
2025-10-19 11:44:20
Check Details
常见的肾癌靶向药物有哪些?
2025-10-19 11:44:20
Check Details
KEYTRUDA和阿昔替尼联合治疗转移性肾细胞癌
2025-10-19 11:44:20
Check Details
帕唑帕尼为晚期肾细胞癌患者提供新选择
2025-10-19 11:44:20
Check Details
服用索坦(舒尼替尼)的推荐剂量
2025-10-19 11:44:20
Check Details
肾癌术后的护理
2025-10-19 11:44:20
Check Details
舒尼替尼晚期肾癌患者一线治疗
2025-10-19 11:44:20
Check Details
乐伐替尼联合依维莫司用于晚期肾癌患者的治疗
2025-10-19 11:44:20
Check Details
1
2
...
8145
8146
8147
8148
8149
8150
8151
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
2
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
3
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
4
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
5
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
6
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
7
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
8
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
9
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
10
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
11
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
12
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial